In conclusion, our study demonstrates that CTGF transcript and protein levels in lung cancerous tissues from NSCLC patients are significantly reduced compared with matched normal control specimens and that the expression of CTGF in NSCLC can be epigenetically regulated and restored. This evidence concerns the gene CCN2 and non-small cell lung carcinoma.